Connect your AI

OrthoPediatrics KIDS Increase (Decrease) in Accounts and Notes Receivable

Increase (Decrease) in Accounts and Notes Receivable at other companies

MedtronicMDT

——

Other financials

Income statement

Revenue$59.4M+13.3%

Gross profit$43.4M+13.4%

Operating income-$8.3M+24.1%

Net income-$10.7M-0.3%

EPS (diluted)-$0.45+2.2%

Balance sheet

Cash & equivalents$14.2M-59.8%

Total debt$5.4M+271%

Total equity$338.7M-2.4%

Total assets$502.2M+6.8%

Cash flow

Operating cash flow-$3.3M+20.9%

CapEx$1.8M-58.4%

Free cash flow-$5.0M+39.8%

Valuation

Market cap$503.94M+0.3%

Enterprise value$495.11M+5.7%

P/S2.1×-0.3×

Profitability

Gross margin73.1%+0.3pp

Operating margin-15%-1.6pp

Net margin-16.3%-2.1pp

FCF margin-12.9%-4.3pp

Returns & leverage

Return on equity-11.6%+0.2pp

Debt / equity0×0.0×

Current ratio5.2×-1.0×

Where this comes from

Reported directly by OrthoPediatrics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable.

The official record: OrthoPediatrics’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about OrthoPediatrics's increase (decrease) in accounts and notes receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is OrthoPediatrics's increase (decrease) in accounts and notes receivable?: OrthoPediatrics (KIDS) reported increase (decrease) in accounts and notes receivable of $183K in Q1 2026.
How has OrthoPediatrics's increase (decrease) in accounts and notes receivable changed year-over-year?: OrthoPediatrics's increase (decrease) in accounts and notes receivable decreased by 87.8% year-over-year, from $1.5M to $183K.